EHC Stock: Do Valuation and Expansion Trends Support a Hold Strategy?

Core Insights - Encompass Health Corporation (EHC) is a leading provider of inpatient rehabilitation services in the U.S., focusing on high-quality rehabilitation care for patients recovering from serious injuries, illnesses, or surgeries [2][3] Company Overview - EHC operates 173 inpatient rehabilitation hospitals across 39 U.S. states and Puerto Rico, with a market capitalization of approximately $10 billion [3] - The company's shares have gained 2.7% over the past year, underperforming the industry's average increase of 5.9% during the same period [3] Valuation Metrics - EHC's forward P/E ratio is 16.71x, lower than the industry average of 17.51x, indicating a relatively attractive valuation [4] - The company holds a Zacks Rank 3 (Hold) and a Value Score of B [4] Earnings Estimates - The Zacks Consensus Estimate for EHC's 2026 earnings is $5.90 per share, suggesting an 8.3% year-over-year increase [5] - The consensus estimate for 2026 revenues is $6.4 billion, indicating 8.3% year-over-year growth, with expected revenues of $6.365–$6.465 billion, up from $5.9 billion in 2025 [5] Growth Drivers - EHC is focused on expanding its Inpatient Rehabilitation segment, having opened eight de novo hospitals with 395 beds in 2023 and plans for further expansions [7][10] - The company reported a 10.5% year-over-year increase in revenues in 2025, driven by an expanding patient base [11] Financial Performance - EHC generated $818 million in adjusted free cash flow in 2025, supporting expansion, buybacks, and dividends [9] - Net operating cash flow increased by 17.9% in 2024 and 17.2% in 2025, reaching $1.2 billion [11] - The company returned value to shareholders through $71.1 million in dividends and $158 million in share repurchases [12] Return on Investment - EHC boasts a trailing 12-month return on invested capital (ROIC) of 10%, surpassing the industry average of 6.3%, indicating efficient use of investments [13]